Bicara Therapeutics Inc.

Q2 2026 13F Holders

Symbol
BCAX
CUSIP
055477103
Type
Equity
Class
COM
Num filings
180
Total reported value, excl. options
$2.11 B
Manager Report Date Value ($000) Shares Option Type